Merck & Co., Inc.
MRK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $5,787,000 | $4,429,000 | $5,085,000 | $3,744,000 |
| Dep. & Amort. | $1,154,000 | $1,119,000 | $1,099,000 | $1,197,000 |
| Deferred Tax | -$212,000 | -$448,000 | -$186,000 | -$616,000 |
| Stock-Based Comp. | $204,000 | $216,000 | $195,000 | $187,000 |
| Change in WC | $5,971,000 | -$2,259,000 | -$3,712,000 | -$1,855,000 |
| Other Non-Cash | -$5,082,000 | $236,000 | $19,000 | $793,000 |
| Operating Cash Flow | $7,822,000 | $3,293,000 | $2,500,000 | $3,450,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$987,000 | -$764,000 | -$1,328,000 | -$937,000 |
| Net Acquisitions | $0 | $0 | $0 | -$2,000 |
| Inv. Purchases | -$473,000 | -$612,000 | -$685,000 | -$455,000 |
| Inv. Sales/Matur. | $575,000 | $601,000 | $456,000 | $7,000 |
| Other Inv. Act. | $602,000 | $5,000 | $70,000 | -$57,000 |
| Investing Cash Flow | -$283,000 | -$770,000 | -$1,487,000 | -$1,444,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $48,000 | -$2,500,000 | -$539,000 |
| Stock Issued | $0 | $0 | $19,000 | $0 |
| Stock Repurch. | $2,490,000 | -$1,345,000 | -$1,164,000 | -$489,000 |
| Dividends Paid | -$2,031,000 | -$2,077,000 | -$2,050,000 | -$1,951,000 |
| Other Fin. Act. | $2,179,000 | -$182,000 | -$60,000 | -$30,000 |
| Financing Cash Flow | $2,638,000 | -$3,556,000 | -$5,755,000 | -$3,009,000 |
| Forex Effect | $10,000 | $374,000 | $156,000 | -$367,000 |
| Net Chg. in Cash | $10,187,000 | -$659,000 | -$4,586,000 | -$1,370,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,073,000 | $8,732,000 | $13,318,000 | $14,688,000 |
| End Cash | $18,260,000 | $8,073,000 | $8,732,000 | $13,318,000 |
| Free Cash Flow | $6,835,000 | $2,529,000 | $1,172,000 | $2,513,000 |